Cargando…
Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma
BACKGROUND: Zc3h12d is a negative regulator which plays a crucial role in immune modulation. However, the role of zc3h12d in lung adenocarcinoma (LUAD) remains unclear. We aim to explore the prognostic of zc3h12d and investigate the relationship between zc3h12d expression and immune infiltration in...
Autores principales: | Yang, Bo, Ji, Lin-Lin, Xu, Hong-Liang, Li, Xiao-Ping, Zhou, Hong-Gang, Xiao, Ting, Li, Xiao-He, Gao, Zhou-Yong, Li, Jian-Zhong, Zhang, Wei-Dong, Wang, Guang-Shun, Li, Ming-Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214544/ https://www.ncbi.nlm.nih.gov/pubmed/34163207 http://dx.doi.org/10.2147/JIR.S304278 |
Ejemplares similares
-
ZC3H12D is a prognostic biomarker associated with immune cell infiltration in lung adenocarcinoma
por: Gong, Wangang, et al.
Publicado: (2020) -
ZC3H12B/MCPIP2, a new active member of the ZC3H12 family
por: Wawro, Mateusz, et al.
Publicado: (2019) -
DNA Methylation Profiling Reveals the Change of Inflammation-Associated ZC3H12D in Leukoaraiosis
por: Huang, Wen-Qing, et al.
Publicado: (2018) -
ZC3H12A Expression in Different Stages of Colorectal Cancer
por: Chen, Tao, et al.
Publicado: (2019) -
Targeted Disruption of MCPIP1/Zc3h12a Results in Fatal Inflammatory Disease
por: Miao, Ruidong, et al.
Publicado: (2013)